Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Silk Road Medical

evt | Article | August 2020 Supplement

Playing Nice in the TCAR Sandbox

How to start and run a strong multidisciplinary TCAR program.

By Meghan Dermody, MD, FACS, FSVS, and Todd Wood, MD, FACC, FSCAI, FSVM

Sponsored by Silk Road Medical

evt | Article | January 2022 Supplement

The Case for TCAR as the “New” Standard for Carotid Revascularization

An assessment of patient selection, patient preference, and excellent outcomes.

By Jeffrey Jim, MD, MPHS; Meghan Dermody, MD; and Marc Schermerhorn, MD

evt | Article | August 2025

Effects of the Carotid Artery Stenting NCD on Current Decision-Making for Carotid Disease

Impact of the NCD on referrals and volumes of transfemoral carotid artery stenting, the multidisciplinary approach to evaluation and treatment, considering patient factors and patient preference, device selection, and approaches to concomitant stroke and carotid disease.

With Meghan Dermody, MD, and Adnan Siddiqui, MD, PhD

evt | News | November 4, 2024

ROADSTER 3 Data Reported for Boston Scientific’s Enroute TCAR Devices

November 4, 2024—The prospective, multicenter ROADSTER 3 postapproval trial is evaluating the safety and effectiveness of transcarotid artery revascularization (TCAR) using the Enroute transcarotid stent system (TSS; Boston Scientific Corporation) in conjunction with the Enroute transcarotid neuroprotection system (NPS; Boston Scientific Corporation) for the treatment of carotid stenosis in standard surgical-risk patients.

Advertisement

Advertisement

evt | Article | August 2025

Modern Pathways in Vascular Care

By Peter A. Schneider, MD

evt | News | June 15, 2022

Silk Road Medical Enroute System Will Be Evaluated in Postmarket ROADSTER 3 Study of TCAR for Standard-Risk Patients

June 15, 2022—Silk Road Medical, Inc. announced a prospective study to evaluate the company’s TCAR system for transcarotid artery revascularization in the treatment of standard surgical risk patients with carotid artery disease.

evt | News | September 7, 2022

Silk Road Medical Begins ROADSTER 3 Postapproval Study of TCAR System in Patients at Standard Surgical Risk

September 7, 2022—Silk Road Medical, Inc. announced enrollment of the first patient in the ROADSTER 3 postapproval study of the company’s system for transcarotid artery revascularization (TCAR) of patients at standard surgical risk with carotid artery disease in real-world treatment.


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button